Efficacy and Safety of AMR101 (Ethyl Icosapentate) in Patients With Fasting Triglyceride (Tg) Levels ≥ 500 and ≤ 2000 mg/dL
Condition(s):HypertriglyceridemiaLast Updated:April 25, 2022Completed
Hide Studies Not Open or Pending
Condition(s):HypertriglyceridemiaLast Updated:April 25, 2022Completed
Condition(s):HypertriglyceridemiaLast Updated:April 25, 2022Completed
Condition(s):COVID-19; Inflammatory ResponseLast Updated:December 22, 2021Completed
Condition(s):COVID19Last Updated:September 17, 2021Completed
Condition(s):Alzheimer’s DiseaseLast Updated:December 11, 2023Completed
Condition(s):HypertriglyceridemiaLast Updated:August 17, 2016Completed
Condition(s):Liver Metastasis; Colon CancerLast Updated:December 6, 2023Active, not recruiting
Condition(s):Type 2 Diabetes; Coronary Artery DiseaseLast Updated:March 18, 2022Terminated
Condition(s):HypertriglyceridemiaLast Updated:August 1, 2019Completed
Condition(s):Colon Cancer Liver MetastasisLast Updated:November 28, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.